Market Overview

The Australia and New Zealand tile adhesive market was USD 55.85 million in 2021. The market is projected to reach USD 104.51 million by the end of the forecast period at a CAGR of 7.26%.

In terms of volume, the Australia and New Zealand market was 101.90 kilotons in 2021 and is anticipated to register a CAGR of 6.46% during the forecast period.

The Australia and New Zealand tile adhesive market is prominently influenced by many market-driven factors. Some of the market-driven factors, which are slated to fuel the Australia and New Zealand market growth include growing demand for tile, rising disposable income, and rapid urbanization.

Apart from these factors, growing investment in residential as well as non-residential construction activities across the globe is projected to trigger Australia and New Zealand tile adhesive market growth.

Residential construction is a leading segment in the tile adhesive market based on its end use. Non-residential construction is commercial and institutional. The commercial construction activities include new construction, replacement, and transportation activities. Demand for decorative tiles in commercial construction offers a good perspective, which is expected to drive the tile adhesives market.

Decorative tile can be installed in malls, airports, office buildings, retail outlets, and commercial buildings, with uses including flooring, wall coverings, and other applications. The demand is dominated by the floor covering applications for decorative, ceramic, vitrified, and other tiles as consumer preference have shifted from carpets and rugs to tiles, which will continue to spur the demand for tile adhesives.

Market Segmentation

According to our analysis, the Australia and New Zealand tile adhesive market is segmented into type, chemistry, application, end-use, and region. Based on type, the tile adhesive market is segmented into cementitious, dispersion, and reactive tile adhesive. The cementitious segment accounted for the largest market share of 75.78% in 2021 with a market value of USD 42.32 million.

Based on chemistry, the market is segmented as vinyl acetate ethylene, VAE-volva, acrylic, styrene-butadiene, epoxy, polyurethane, and others. Acrylic accounted for the largest value market share of 29.61% in 2021 due to its use in cementitious tile adhesive (as an additive) as well as dispersion tile adhesive (purely acrylic dispersion).

The prominent application of tile adhesives includes ceramic tile followed by ceramic tile, vitrified tiles, mosaic and glass, natural stone, and others. The segment is anticipated to register the highest CAGR of 7.61% during the forecast period due to the growing demand for ceramic tiles in various applications such as flooring, walls, kitchen counters, patios, and walkways. Based on end use, the market is segmented as residential, commercial, and institutional. The residential segment accounted for the largest market share of 65.54% in 2021 with a market value of USD 70.92 million.

Major Players

Henkel AG & Co KgaA, Bostik, BASF SE, Henkel AG & Co KgaA, Sika AG, and Saint-Gobain Weber

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY
1.1.1 MARKET ATTRACTIVENESS ANALYSIS
1.1.2 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY TYPE
1.1.3 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY CHEMISTRY
1.1.4 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY APPLICATION
1.1.5 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY END USE
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
3.6 LIST OF ASSUMPTIONS & LIMITATIONS
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 BOOMING CONSTRUCTION INDUSTRY
4.2.2 GROWING TILE MARKET
4.2.3 INCREASING DEMAND FOR CEMENTITIOUS TILE ADHESIVE
4.2.4 DRIVERS IMPACT ANALYSIS
4.3 RESTRAINTS
4.3.1 LOW PROFIT MARGINS AND LOW AWARENESS REGARDING TILE ADHESIVES
4.3.2 RESTRAINTS IMPACT ANALYSIS
4.4 OPPORTUNITIES
4.4.1 INNOVATIVE LOW VOC TILE ADHESIVE
4.5 CHALLENGE
4.5.1 USE OF POLYMER-BASED CEMENTITIOUS TILE ADHESIVE
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 RAW MATERIALS SUPPLIERS
5.1.2 TILE ADHESIVES MANUFACTURERS
5.1.3 DISTRIBUTION CHANNELS
5.1.4 END USERS
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID 19 OUTBREAK ON THE AUSTRALIA AND NEW ZEALAND TILE ADHESIVES MARKET
5.3.1 IMPACT OF COVID 19 ON THE SUPPLY CHAIN OF TILE ADHESIVES
5.3.2 QUALITATIVE ANALYSIS ON CHANGE IN DEMAND FOR TILE ADHESIVES DUE TO COVID 19
6 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY TYPE
6.1 OVERVIEW
6.1.1 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE: MARKET ESTIMATES & FORECAST BY TYPE, 2019–2030
6.1.2 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE: MARKET ESTIMATES & FORECAST BY TYPE, 2019–2030
7 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY CHEMISTRY
7.1 OVERVIEW
7.1.1 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE: MARKET ESTIMATES & FORECAST BY CHEMISTRY, 2019–2030
7.1.2 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE: MARKET ESTIMATES & FORECAST BY CHEMISTRY, 2019–2030
8 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY APPLICATION
8.1 OVERVIEW
8.1.1 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE: MARKET ESTIMATES & FORECAST BY APPLICATION, 2019–2030
8.1.2 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE: MARKET ESTIMATES & FORECAST BY APPLICATION, 2019–2030
9 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY END-USE
9.1 OVERVIEW
9.1.1 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE: MARKET ESTIMATES & FORECAST BY END-USE, 2019–2030
9.1.2 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE: MARKET ESTIMATES & FORECAST BY END-USE, 2019–2030
10 AUSTRALIA AND NEW ZEALAND TILE ADHESIVE MARKET, BY REGION
10.1 OVERVIEW
10.2 AUSTRALIA
10.3 NEW ZEALAND
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 RECENT DEVELOPMENTS, MERGERS/ACQUISITIONS
11.3 AUSTRALIA AND NEW ZEALAND MARKET STRATEGY ANALYSIS
11.4 MARKET SHARE ANALYSIS, KEY PLAYERS, 2021 (%)
11.5 COMPETITIVE BENCHMARKING, TILE ADHESIVE BRANDS
12 COMPANY PROFILES
12.1 BOSTIK
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 SIKA AG
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENT
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 SAINT GOBAIN WEBER S.A.
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 BASF SE
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 3M
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 DUPONT INC.
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 HENKEL AG & CO KGAA
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 H.B. FULLER
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 MAPEI SPA
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 DUNLOP
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
12.11 BAYSET
12.11.1 COMPANY OVERVIEW
12.11.2 FINANCIAL OVERVIEW
12.11.3 PRODUCTS OFFERED
12.11.4 KEY DEVELOPMENTS
12.11.5 SWOT ANALYSIS
12.11.6 KEY STRATEGIES
12.12 ARDEX
12.12.1 COMPANY OVERVIEW
12.12.2 FINANCIAL OVERVIEW
12.12.3 PRODUCTS OFFERED
12.12.4 KEY DEVELOPMENTS
12.12.5 SWOT ANALYSIS
12.12.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS

The post Australia And New Zealand Tile Adhesive Market Research Report Forecast to 2030 first appeared on CRI Report.

Market Segmentation

• Product – Software and Services (License and Maintenance)
• Genomic Platform – Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Other Genomic Platforms
• Applications – Research (Omics-Data Analysis, Population Sequencing, Annotation and Gene Expression, and Other Research Applications) and Clinical (Oncology, Rare Diseases, Infectious diseases, Sexual and Reproductive Health, and Other Clinical Applications)
• End User – Research and Academic Institutions, Biotechnology and Biopharmaceutical Companies, Hospitals and Diagnostic Laboratories, Contract Research Organizations, Forensic Laboratories, and Other End Users

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, Spain, Netherlands, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

Growth Drivers

• Decreasing Cost of Sequencing
• Global Increase in Cancer Prevalence
• Increasing Number of Population Genomics Initiative

Market Challenges

• Lack of High Complexity Genomic Testing Centers in High Potential Markets
• Challenges Pertaining to Genomic Data Storage
• Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic Capabilities

Market Opportunities

• Massive Scope for the Adoption of Genomic Data Analysis Software in the Emerging Nations
• Novel Diagnostic Applications

Key Companies Profiled

10x Genomics, Inc., Agilent Technologies, Inc., ASURAGEN INC., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Bio-Rad Laboratories, Inc., DNASTAR, F. Hoffmann-La Roche Ltd., Golden Helix, Inc., Illumina, Inc., Oxford Nanopore Technologies, Inc., Pacific Biosciences of California, Inc., Partek Inc., QIAGEN N.V., SoftGenetics LLC, and Thermo Fisher Scientific Inc.

Key Questions Answered in this Report:

• How is genomic data analysis and interpretation revolutionizing the field of research and diagnostics?
• What are the major market drivers, challenges, and opportunities in the global genomic data analysis and interpretation market?
• What are the underlying structures resulting in the emerging trends within the global genomic data analysis and interpretation market?
• How the COVID-19 pandemic impacted the genomic data analysis and interpretation landscape?
• What are the key development strategies which are being implemented by the major players in order to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to genomics?
• What are the potential entry barriers expected to be faced by the companies willing to enter in a particular region?
• How is each segment of the market expected to grow during the forecast period from 2020 to 2030, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
o Product Type (Software and Services)
o Genomic Platform (NGS, PCR, Microarray, and Others)
o Application (Research and Clinical)
o End User (Research and Academic Institutions, Biotechnology and Pharmaceutical Companies, Corporate Research Organizations, Hospitals and Diagnostic Laboratories, Forensic Laboratories, and Others)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the companies in the region of their operation?
• Who are the leading players with significant offerings to the global genomic data analysis and interpretation market? What is the expected market dominance for each of these leading players?
• Which companies are anticipated to be highly disruptive in the future and why?
• What are the current unmet needs that are being faced?

Market Overview

Healthcare experts at BIS have found genomic data analysis and interpretation industry to be one of the most rapidly evolving and dynamic markets and the global market for Genomic data analysis and interpretation is predicted to grow at a CAGR of 10.21% over the forecast period of 2020-2030. The market is driven by certain factors, which include decreasing cost of sequencing, global increase in cancer prevalence, and increasing number of population genomics initiative, among others, are fueling the growth of the global genomic data analysis and interpretation market.

The market is favored by the developments in the field of genomics and bioinformatics. Currently, the genomic data analysis and interpretation industry is witnessing an upsurge due to the growing number of genomic research initiatives being undertaken by the developing and developed countries coupled with the decreasing cost of sequencing, resulting in the high demand for software solutions for genomic data analysis. Additionally, high adoption of sequencing instruments by the researchers and clinicians, coupled with the growing prevalence of complex diseases, such as cancer, are some of the critical factors expected to bolster the market growth.

Furthermore, biotechnology companies are focusing on the development of robust genomic data analysis software solutions for a wide range of clinical applications to support clinicians in conducting an in-depth analysis.

Within the research report, the market is segmented on the basis of product, genomic platform, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the number of cases associated with cancer has created a buzz among the biotechnology companies to further invest in the development of reliable genomic software solutions for data analysis, further aiding clinicians to offer precision oncology treatments. Due to the presence of a diverse product portfolio and intense market penetration, Thermo Fisher Scientific Inc. has been a pioneer in this field and has been a significant competitor in this market.

On the basis of region, North America holds the largest share of the genomic data analysis and interpretation market due to high infusion of funding from the government organizations for conducting research on genomics and bioinformatics, rising prevalence of cancer, growing awareness about precision medicine, and decreasing cost of sequencing, among others. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period, 2020-2030.

The post Global Genomic Data Analysis and Interpretation Market: Focus on Products, Genomic Platforms, Applications, End Users, Country Data (15 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2030 first appeared on CRI Report.